Dimerix Stock

Dimerix FCF Margin

The Free Cash Flow Margin of Dimerix (DXB.AX) as of Sep 3, 2026 is 660.01 %. In the previous year, Free Cash Flow Margin was -1,203.05 % — a change of -154.86% (higher).

FCF Margin

660.01 %

YoY

-154.86%

Last updated:

Free Cash Flow Margin of Dimerix is 2026 660.01 % . Free Cash Flow Margin of Dimerix was 2025 -1,203.05 % . It decreases by -154.86% higher compared to the previous year.

The Dimerix FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2018
-15,984.65 AUD
Jan 1, 2019
-15,235.91 AUD
Jan 1, 2020
-174,870.37 AUD
Jan 1, 2021
-424,666.67 AUD
Jan 1, 2022
-560,270.83 AUD
Jan 1, 2023
-34,595.11 AUD
Jan 1, 2024
-1,203.05 AUD
Jan 1, 2025
660.01 AUD
The Dimerix FCF Margin history
YEARFCF MarginYoY
660.01 %-154.86%
-1,203.05 %-96.52%
-34,595.11 %-93.83%
-560,270.83 %+31.93%
-424,666.67 %+142.85%
-174,870.37 %+1,047.75%
-15,235.91 %-4.68%
-15,984.65 %+56.68%
-10,202.19 %+234.63%
-3,048.79 %+72.83%
-1,764.01 %+23.79%
-1,425.00 %
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Free Cash Flow Margin of Dimerix is 660.01 % in 2026.

Free Cash Flow Margin of Dimerix changed from -1,203.05 % to 660.01 %, representing a -154.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Dimerix since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Dimerix

All Key Metrics — Dimerix